Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
gucixiao cataplasm
- Development stage
- Unknown
- Lead developer
- Guizhou Bailing Group Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
Gucixiao Cataplasm is a Traditional Chinese Medicine (TCM) topical hydrogel patch developed by Guizhou Bailing Group Pharmaceutical for the treatment of orthopedic conditions characterized by pain and inflammation. The formulation contains a complex mixture of herbal extracts, including Ligusticum wallichii, Psoralea corylifolia, and Angelica pubescens, which are traditionally used to promote blood circulation and alleviate stasis. Indicated for bone hyperplasia, cervical spondylosis, and osteoarthritis, the cataplasm provides a cooling sensation upon application and ensures the sustained transdermal delivery of active constituents to the affected joint or bone area, thereby reducing local swelling and improving mobility.
- Brand names
- Bailing百灵
- Other names
- 骨刺消巴布剂Gucixiao Babuji
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on gucixiao cataplasm.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on gucixiao cataplasm.